Mechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection.
Level 5 - mechanism / opinion, no new human data
Narrative review describing preclinical molecular mechanisms without new human data.
PubMed 28249278 · doi:10.1159/000450915
What was done
This narrative review summarizes research on the signaling mechanisms underlying the hepatoprotective, choleretic, anti-apoptotic, and stem-cell differentiating effects of tauroursodeoxycholate (TUDC).
What was found
The abstract reports no numerical data. Mechanistically, TUDC binds to α5β1-integrin, causing a conformational activation of the β1 subunit that triggers focal adhesion kinase, c-Src, EGFR, Erks, and p38 MAPK signaling. This cascade stimulates choleresis via coordinated membrane insertion of the sodium-taurocholate cotransporting polypeptide (NTCP) basolaterally and the bile salt export pump (BSEP) canalicularly. TUDC-mediated integrin activation also engages cAMP-dependent protein kinase A to mediate anti-apoptotic effects and reduce endoplasmic reticulum stress, while TUDC-induced mesenchymal stem cell differentiation proceeds via integrin-independent mechanisms.
Why it matters
It provides a molecular explanation for the empirical hepatoprotective actions of TUDC, demonstrating that its actions rely on integrin signaling pathways rather than standard bile acid receptors like FXR or TGR5.
Limits
As a narrative review, it presents no quantitative statistical endpoints, human clinical data, or sample sizes. The abstract does not specify the exact pathway governing the integrin-independent differentiation of mesenchymal stem cells.
Cited by
- supports TUDCA thins biliary sludge in the bile ducts and reduces liver fibrosis.